242 related articles for article (PubMed ID: 27145235)
21. Osteosarcomas after the age of 50: a clinicopathologic study of 64 cases--an experience in northern Japan.
Okada K; Hasegawa T; Nishida J; Ogose A; Tajino T; Osanai T; Yanagisawa M; Hatori M
Ann Surg Oncol; 2004 Nov; 11(11):998-1004. PubMed ID: 15525829
[TBL] [Abstract][Full Text] [Related]
22. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
23. Marginal resection for osteosarcoma with effective preoperative chemotherapy.
Yu XC; Xu M; Song RX; Xu SF
Orthop Surg; 2009 Aug; 1(3):196-202. PubMed ID: 22009842
[TBL] [Abstract][Full Text] [Related]
24. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
25. Custom prosthetic reconstruction for proximal tibial osteosarcoma with proximal tibiofibular joint involved.
Zhang Y; Yang Z; Li X; Chen Y; Zhang S; Du M; Li J
Surg Oncol; 2008 Aug; 17(2):87-95. PubMed ID: 18160278
[TBL] [Abstract][Full Text] [Related]
26. Marginal excision for osteosarcoma with caffeine assisted chemotherapy.
Tsuchiya H; Tomita K; Mori Y; Asada N; Yamamoto N
Clin Orthop Relat Res; 1999 Jan; (358):27-35. PubMed ID: 9973973
[TBL] [Abstract][Full Text] [Related]
27. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of extremity osteosarcoma in patients aged 40-60 years: a cohort/case controlled study at a single institute.
Song WS; Kong CB; Jeon DG; Cho WH; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
Eur J Surg Oncol; 2010 May; 36(5):483-8. PubMed ID: 20363585
[TBL] [Abstract][Full Text] [Related]
29. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response.
Lewis VO; Raymond K; Mirza AN; Lin P; Yasko AW
Clin Orthop Relat Res; 2006 Sep; 450():60-6. PubMed ID: 16906104
[TBL] [Abstract][Full Text] [Related]
30. Correlation between fluid-fluid levels on initial MRI and the response to chemotherapy in stage IIb osteosarcoma.
Jeon DG; Cho WH; Song WS; Kong CB; Cho SH; Lee JW; Lee SY
Ann Surg Oncol; 2014 Jun; 21(6):1956-62. PubMed ID: 24577812
[TBL] [Abstract][Full Text] [Related]
31. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
[TBL] [Abstract][Full Text] [Related]
32. Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.
Prabowo Y; Setiawan I; Kamal AF; Kodrat E; Labib Zufar ML
Int J Surg Oncol; 2021; 2021():8843325. PubMed ID: 33996154
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
[TBL] [Abstract][Full Text] [Related]
34. Fibular osteosarcomas: contaminated margins may not impact survival.
Schneiderbauer MM; Gullerud R; Harmsen WS; Scully SP
Clin Orthop Relat Res; 2007 Mar; 456():182-7. PubMed ID: 16967031
[TBL] [Abstract][Full Text] [Related]
35. Pathologic fracture a poor prognostic factor in osteosarcoma: Misleading conclusions from meta-analyses?
Cates JM
Eur J Surg Oncol; 2016 Jun; 42(6):883-8. PubMed ID: 26895688
[TBL] [Abstract][Full Text] [Related]
36. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
[TBL] [Abstract][Full Text] [Related]
37. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
38. The effect of local extent of the tumor on prognosis in osteosarcoma.
Spanier SS; Shuster JJ; Vander Griend RA
J Bone Joint Surg Am; 1990 Jun; 72(5):643-53. PubMed ID: 2355025
[TBL] [Abstract][Full Text] [Related]
39. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging.
Lawrence JA; Babyn PS; Chan HS; Thorner PS; Pron GE; Krajbich IJ
Radiology; 1993 Oct; 189(1):43-7. PubMed ID: 8372217
[TBL] [Abstract][Full Text] [Related]
40. Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.
Pruksakorn D; Phanphaisarn A; Arpornchayanon O; Uttamo N; Leerapun T; Settakorn J
Cancer Epidemiol; 2015 Dec; 39(6):956-63. PubMed ID: 26540607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
